TrialBone marrow transplantation2017

A multicenter trial of myeloablative clofarabine and busulfan conditioning for relapsed or primary induction failure AML not in remission at the time of allogeneic hematopoietic stem cell transplantation.

J Magenau et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.